Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
83.03
+1.22 (1.49%)
May 8, 2026, 4:00 PM EDT - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $6.2 billion as of May 8, 2026. Its market cap has increased by 188.20% in one year.
Market Cap
6.20B
Enterprise Value
5.31B
1-Year Change
188.20%
Ranking
Category
Stock Price
$83.03
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $6.20B, an increase of 666.80%. That is a compound annual growth rate of 105.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 6.20B | 21.76% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 6.53B |
| Celcuity | 6.43B |
| TG Therapeutics | 6.42B |
| Protagonist Therapeutics | 6.40B |
| Spyre Therapeutics | 6.39B |
| Mirum Pharmaceuticals | 6.33B |
| Centessa Pharmaceuticals | 6.12B |
| Belite Bio | 6.10B |